Harnessing The Full Potential of Cell Therapy

Inceptor Bio is Pioneering Next-Generation Cell Therapies to Cure Solid Tumors

CAR-M Cell Therapy Microsopic Cells

Our Singular Focus:
To Advance Cell Therapies To Cure Cancer

Inceptor Bio is committed to confronting one of humanity’s single most complex problems — solid tumor cancers. Every day, we are working to develop and deliver therapies that have the potential to cure patients.

OUTLASTTM CAR T: Reprogramming T cells to Maintain Stemness and Effector Function in the Tumor Micro environment

At Inceptor Bio, we’re transforming immunotherapy with our cutting-edge CAR T platform. Our approach integrates proprietary technology that reprograms T cells into a stem-like, durable anti-tumor phenotype. 

The process is easy to implement across different process and T cell products.

Scientist in laboratory to show how CAR-M infiltrate and deliver therapy

Resist Exhaustion

OUTLASTTM CAR T cells exhibit superior activation and resist exhaustion even after long term activity in vivo in an aggressive solid tumor model

Tumor cells show CAR-M increasing phagocytosis to eradicate cancer

Enhance Durability

OUTLASTTM induces a gene expression profile associated with stem-like, early memory T cell phenotype

Cells to show how CAR-M orchestrates immune responses

Retain Function

OUTLASTTM T cells maintain effector function even in an immune suppressive environment

Stay Up to Date on Inceptor